SSY Group Limited

OTCPK:LJUI.F Stock Report

Market Cap: US$1.7b

SSY Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:LJUI.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
16 May 25BuyUS$655,822China Pharmaceutical Company LimitedCompany1,776,000US$0.37
29 Apr 25BuyUS$380,864China Pharmaceutical Company LimitedCompany1,000,000US$0.38
16 Apr 25BuyUS$532,735China Pharmaceutical Company LimitedCompany1,400,000US$0.38
15 Apr 25BuyUS$226,719Jiguang QuIndividual580,000US$0.39
11 Apr 25BuyUS$310,534Jiguang QuIndividual800,000US$0.39
09 Apr 25BuyUS$116,879China Pharmaceutical Company LimitedCompany300,000US$0.39
07 Apr 25BuyUS$2,320,722China Pharmaceutical Company LimitedCompany6,000,000US$0.39
03 Apr 25BuyUS$1,294,197China Pharmaceutical Company LimitedCompany3,000,000US$0.43
01 Apr 25BuyUS$607,118Jiguang QuIndividual1,400,000US$0.43
01 Apr 25BuyUS$1,296,534China Pharmaceutical Company LimitedCompany3,000,000US$0.43
31 Mar 25BuyUS$1,148,440China Pharmaceutical Company LimitedCompany2,800,000US$0.41
21 Feb 25SellUS$155,318UBS Asset Management AGCompany372,000US$0.42
20 Feb 25BuyUS$84,922UBS Asset Management AGCompany198,000US$0.43
18 Feb 25SellUS$186,644UBS Asset Management AGCompany448,204US$0.42
08 Jan 25BuyUS$209,717China Pharmaceutical Company LimitedCompany500,000US$0.42
07 Jan 25BuyUS$257,443China Pharmaceutical Company LimitedCompany600,000US$0.43
06 Jan 25BuyUS$261,485China Pharmaceutical Company LimitedCompany600,000US$0.44
03 Jan 25BuyUS$286,105China Pharmaceutical Company LimitedCompany660,000US$0.43
26 Nov 24BuyUS$582,998Jiguang QuIndividual1,300,000US$0.45
20 Nov 24BuyUS$199,387Jiguang QuIndividual400,000US$0.50
19 Nov 24BuyUS$436,199Jiguang QuIndividual900,000US$0.48
15 Nov 24BuyUS$488,979China Pharmaceutical Company LimitedCompany1,000,000US$0.49
14 Nov 24BuyUS$490,433China Pharmaceutical Company LimitedCompany1,000,000US$0.49
30 Oct 24BuyUS$373,134China Pharmaceutical Company LimitedCompany780,000US$0.48
29 Oct 24BuyUS$618,173China Pharmaceutical Company LimitedCompany1,280,000US$0.48
21 Oct 24BuyUS$401,115China Pharmaceutical Company LimitedCompany800,000US$0.50
14 Oct 24BuyUS$532,945China Pharmaceutical Company LimitedCompany1,000,000US$0.53
08 Oct 24BuyUS$448,455China Pharmaceutical Company LimitedCompany800,000US$0.56
04 Oct 24BuyUS$170,733China Pharmaceutical Company LimitedCompany300,000US$0.57
25 Sep 24BuyUS$492,193China Pharmaceutical Company LimitedCompany1,000,000US$0.49
24 Sep 24BuyUS$610,966Jiguang QuIndividual1,230,000US$0.50
23 Sep 24BuyUS$403,517China Pharmaceutical Company LimitedCompany820,000US$0.49
11 Sep 24BuyUS$1,217,763China Pharmaceutical Company LimitedCompany2,500,000US$0.49
10 Sep 24BuyUS$493,734China Pharmaceutical Company LimitedCompany1,000,000US$0.49
09 Sep 24BuyUS$641,657China Pharmaceutical Company LimitedCompany1,300,000US$0.49
05 Sep 24BuyUS$1,102,831China Pharmaceutical Company LimitedCompany2,200,000US$0.50
04 Sep 24BuyUS$501,040China Pharmaceutical Company LimitedCompany1,000,000US$0.50
03 Sep 24BuyUS$502,575China Pharmaceutical Company LimitedCompany1,000,000US$0.50
02 Sep 24BuyUS$993,516China Pharmaceutical Company LimitedCompany2,000,000US$0.50
02 Sep 24BuyUS$195,522Jiguang QuIndividual400,000US$0.49
30 Aug 24BuyUS$1,172,328China Pharmaceutical Company LimitedCompany2,350,000US$0.50
21 Aug 24BuyUS$2,690,228Sichuan Kelun Industry Group CO., LTD.Company5,930,000US$0.45

Insider Trading Volume

Insider Buying: LJUI.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of LJUI.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders306,424,00010.3%
Institutions521,772,37917.6%
General Public716,095,00624.1%
Private Companies1,425,752,00048%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 75.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
27.6%
China Pharmaceutical Company Limited
819,030,000US$455.9m0.83%no data
20.4%
Sichuan Kelun Industry Group CO., LTD.
606,722,000US$337.7m0%no data
10.5%
UBS Asset Management AG
311,676,312US$173.5m3.07%0.03%
9.5%
Jiguang Qu
282,008,000US$157.0m1.35%no data
1.84%
The Vanguard Group, Inc.
54,544,554US$30.4m-0.08%no data
1.04%
Dimensional Fund Advisors LP
30,953,933US$17.2m-1.72%no data
0.82%
Xuejun Su
24,416,000US$13.6m0%no data
0.76%
BlackRock, Inc.
22,565,977US$12.6m0.01%no data
0.62%
Norges Bank Investment Management
18,415,986US$10.3m0%no data
0.54%
Fullgoal Fund Management Co., Ltd.
16,062,000US$8.9m0%0.02%
0.4%
UBS SDIC Fund Management Co., Ltd.
11,876,000US$6.6m0%0.12%
0.39%
Nordea Investment Management, AB
11,534,360US$6.4m2.51%no data
0.35%
Bosera Asset Management Co., Ltd.
10,468,000US$5.8m0%0.03%
0.3%
HuaAn Fund Management Company Ltd.
9,024,000US$5.0m0%0.02%
0.11%
State Street Global Advisors, Inc.
3,328,763US$1.9m8.54%no data
0.095%
American Century Investment Management Inc
2,824,000US$1.6m22%no data
0.076%
Storebrand Fonder AB,
2,264,000US$1.3m0%0.01%
0.072%
China Asset Management Co. Ltd.
2,143,288US$1.2m15.4%no data
0.048%
Invesco Great Wall Fund Management Co. Ltd
1,420,000US$790.3k0%no data
0.046%
Wanjia Asset Management Co., Ltd.
1,356,000US$754.8k0%0.01%
0.043%
GAM Holding AG
1,292,000US$719.1k0%0.01%
0.04%
RAM Active Investments S.A.
1,178,000US$655.6k0%0.06%
0.037%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,112,000US$618.9k-20.6%no data
0.034%
Eaton Vance Management
1,024,000US$570.0k0%no data
0.027%
Mackenzie Financial Corporation
794,962US$442.5k323%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/07/29 15:36
End of Day Share Price 2023/05/01 00:00
Earnings2022/12/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

SSY Group Limited is covered by 21 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Derrick SunBNP Paribas Securities (Asia)
Ying ShaoBofA Global Research
Yanyin ZhuChina International Capital Corporation Limited